Literature DB >> 6382585

Renin secretion in advanced diabetic nephropathy.

S Björck, K Delin, H Herlitz, O Larsson, M Aurell.   

Abstract

Low basal and stimulated plasma renin activity (PRA) levels have been reported in patients with diabetic nephropathy (DN). We have measured PRA before and after stimulation with captopril in 28 patients with DN and in 25 control patients. Renal function impairment was similar in both groups. Most patients were treated with furosemide. In 19 patients with DN the PRA-response to dihydralazine was also studied. PRA before and after captopril were higher in the DN than in the control group (p less than 0.001). PRA increased from 4.6 +/- 3.6 to 6.3 +/- 5.3 in the DN, and from 1.8 +/- 2.7 to 2.7 +/- 3.4 in the control patients. The increases in PRA, caused by decreased angiotensin II feed-back inhibition, were comparable. PRA did not increase after dihydralazine despite a pronounced blood-pressure reduction. The difference in response to these stimuli indicate selective lesions involving both the sympathetic innervation and the renal baroreceptor function in DN. Overhydration is a plausible explanation to the low PRA earlier reported in DN. The results thus indicate that a preserved renin secretion capacity is present in DN. Differences in PRA between the both groups can only partly be explained by other factors than DN. Our findings indicate a role for the reninangiotensin-system in hypertension in DN.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6382585

Source DB:  PubMed          Journal:  Scand J Urol Nephrol Suppl        ISSN: 0300-8886


  2 in total

1.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

Authors:  S Björck; G Nyberg; H Mulec; G Granerus; H Herlitz; M Aurell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

2.  Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nyberg; M Aurell
Journal:  BMJ       Date:  1990-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.